In contrast, TKIs (HR 0.57; 95% CI 0.42–0.76) and CDK4/6 inhibitors (HR 0.34; 95% CI 0.30–0.39) were associated with a lower odds of reporting for ILD. The gene discussed is CDK4; the disease is interstitial lung disease.